CD49d Immunophenotyping by Flow Cytometry Test
Comprehensive Introduction to CD49d Immunophenotyping
CD49d Immunophenotyping by Flow Cytometry represents a sophisticated diagnostic approach that plays a pivotal role in modern hematological cancer management. This advanced laboratory technique enables precise identification and characterization of CD49d protein expression on immune cells, providing clinicians with essential information for accurate diagnosis and personalized treatment strategies. The CD49d molecule, also known as integrin alpha-4, serves as a critical cell adhesion protein that influences cancer cell migration, invasion, and survival mechanisms.
What Does the CD49d Test Measure?
The CD49d Immunophenotyping test specifically detects and quantifies the presence of CD49d surface markers on various white blood cell populations. This sophisticated analysis provides:
- Precise identification of CD49d expression levels on lymphocytes and other immune cells
- Characterization of abnormal cell populations in blood and bone marrow samples
- Detection of specific immunophenotypic patterns associated with hematological malignancies
- Quantitative assessment of CD49d-positive cell percentages and intensity
- Identification of disease-specific cellular markers for accurate diagnosis
Who Should Consider CD49d Immunophenotyping?
This specialized test is particularly valuable for patients presenting with:
- Suspected or diagnosed cases of chronic lymphocytic leukemia (CLL)
- Multiple myeloma patients requiring prognostic assessment
- Individuals with unexplained lymphocytosis or abnormal blood counts
- Patients with suspected lymphoma or other hematological malignancies
- Those requiring treatment response monitoring for blood cancers
- Individuals with bone marrow disorders requiring comprehensive evaluation
Clinical Benefits of CD49d Testing
Undergoing CD49d Immunophenotyping provides numerous clinical advantages:
- Enhanced Diagnostic Accuracy: Provides definitive identification of malignant cell populations
- Prognostic Information: CD49d expression levels correlate with disease progression and outcomes
- Treatment Guidance: Helps determine appropriate therapeutic approaches
- Disease Monitoring: Enables tracking of treatment response and disease evolution
- Early Detection: Identifies abnormal cell populations before clinical symptoms manifest
- Personalized Medicine: Supports tailored treatment strategies based on individual biomarker profiles
Understanding Your Test Results
Your CD49d Immunophenotyping results will provide detailed information about:
- CD49d Expression Levels: The percentage and intensity of CD49d-positive cells in your sample
- Cell Population Analysis: Identification of specific lymphocyte subsets expressing CD49d
- Abnormal Patterns: Detection of immunophenotypic abnormalities suggestive of malignancy
- Clinical Correlation: Interpretation of findings in context of your clinical presentation
Your healthcare provider will discuss the significance of your results and develop an appropriate management plan based on the findings. Elevated CD49d expression often indicates more aggressive disease behavior and may influence treatment decisions.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $88 |
| Regular Price | $112 |
Nationwide Testing Availability
We proudly offer CD49d Immunophenotyping testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art flow cytometry laboratories ensure consistent, high-quality results regardless of your location.
Schedule Your Test Today
Take the first step toward comprehensive cancer diagnosis and management. Our experienced team is ready to assist you with scheduling your CD49d Immunophenotyping test. For immediate consultation and appointment booking, contact our dedicated healthcare specialists at +1(267) 388-9828 or visit your nearest GGC DNA testing center.
Important Testing Information: Samples are processed daily with a 9 AM cutoff time for same-day reporting. Required samples include 3 mL whole blood in sodium heparin tubes and/or 2 mL bone marrow in sodium heparin tubes. Proper sample handling is crucial – ship immediately at 18-22°C and do not refrigerate or freeze. Please provide complete clinical history with your test request.
